I Bajjoka

YSPSL (rPSGL‐Ig) for improvement of early renal allograft function: a double‐blind, placebo‐controlled, multi‐center Phase IIa study^1,2,3

A. Osama Gaber, Shamkant Mulgaonkar, Barry D. Kahan et al. · Clinical Transplantation · 2010 · 59 citations

Preserving renal function in liver transplant recipients with rabbit anti-thymocyte globulin and delayed initiation of calcineurin inhibitors

I Bajjoka, Lama Hsaiky, Kimberly Brown et al. · Liver Transplantation · 2007 · 50 citations

Clostridium difficile Infection in Liver Transplant Recipients: A Retrospective Study of Rates, Risk Factors and Outcomes

Chetan Mittal, Syed Adeel Hassan, Samia Arshad et al. · American Journal of Transplantation · 2014 · 46 citations · Full text

Liver Transplant Recipients, Solid Organ Transplantation, Gastroenterology +16

Risperidone-Induced Neuroleptic Malignant Syndrome

I Bajjoka, Tushar R. Patel, T.M. O'SULLIVAN · Annals of Emergency Medicine · 1997 · 43 citations

Neuro-oncology, Neurological Disorder, Medicine +6

The Efficacy and Limitations of Sirolimus Conversion in Liver Transplant Patients Who Develop Renal Dysfunction on Calcineurin Inhibitors

Patrick Lam, Atsushi Yoshida, Kimberly Brown et al. · Digestive Diseases and Sciences · 2004 · 32 citations

Urology, Renal Function, Sirolimus Conversion +8